Adaptimmune Therapeutics (ADAP) Insider Trading & Ownership $0.24 0.00 (-0.75%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.24 0.00 (-0.08%) As of 04/17/2025 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Adaptimmune Therapeutics (NASDAQ:ADAP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.44%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$52,102.42 Get ADAP Insider Trade Alerts Want to know when executives and insiders are buying or selling Adaptimmune Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADAP Insider Buying and Selling by Quarter Adaptimmune Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/17/2025Elliot NorryInsiderSell5,584$0.58$3,238.72 1/15/2025Cintia PiccinaInsiderSell12,991$0.57$7,404.87 1/15/2025William C Bertrand JrCOOSell9,803$0.57$5,587.71 1/13/2025Elliot NorryInsiderSell12,392$0.59$7,311.28 1/13/2025William C Bertrand JrCOOSell9,739$0.59$5,746.01 6/18/2024Cintia PiccinaInsiderSell24,531$0.93$22,813.83 (Data available from 1/1/2013 forward) ADAP Insider Trading Activity - Frequently Asked Questions Who is on Adaptimmune Therapeutics's Insider Roster? The list of insiders at Adaptimmune Therapeutics includes Adrian Rawcliffe, Cintia Piccina, Elliot Norry, Garry E Menzel, Gavin Wood, John Lunger, and William C Bertrand Jr. Learn more on insiders at ADAP. What percentage of Adaptimmune Therapeutics stock is owned by insiders? 12.44% of Adaptimmune Therapeutics stock is owned by insiders. Learn more on ADAP's insider holdings. Which Adaptimmune Therapeutics insiders have been selling company stock? The following insiders have sold ADAP shares in the last 24 months: Adrian Rawcliffe ($21,404.66), Cintia Piccina ($30,218.70), Elliot Norry ($15,724.29), Garry E Menzel ($43,408.82), John Lunger ($2,817.36), and William C Bertrand Jr ($19,468.71). How much insider selling is happening at Adaptimmune Therapeutics? Insiders have sold a total of 168,020 Adaptimmune Therapeutics shares in the last 24 months for a total of $133,042.54 sold. Adaptimmune Therapeutics Key ExecutivesMr. Adrian G. Rawcliffe (Age 52)CEO, Principal Accounting Officer & Director Compensation: $1.06MDr. Helen Katrina Tayton-Martin MBA (Age 57)Ph.D., Co-Founder & Chief Business & Strategy Officer Compensation: $677.4kMr. Gavin Hilary James Wood ACA (Age 54)BA (Hons), Chief Financial Officer Compensation: $666.34kDr. Elliot Norry B.A. (Age 60)M.D., Chief Medical Officer Compensation: $676.19kMs. Joanna Brewer Ph.D. (Age 48)Chief Scientific Officer Dr. Juli P. Miller Ph.D.VP of Corporate Affairs & Investor RelationsMs. Kerry SharpSenior VP & General CouncilDana LynchSenior Director of Corporate CommunicationsMr. John Lunger (Age 54)Chief Patient Supply Officer Compensation: $645.91kMr. Dennis WilliamsSenior Vice President of Late Stage Development More Insider Trading Tools from MarketBeat Related Companies Astria Therapeutics Insider Transactions Compass Therapeutics Insider Transactions Bright Minds Biosciences Insider Transactions Monopar Therapeutics Insider Transactions Nuvectis Pharma Insider Transactions Lifecore Biomedical Insider Transactions Y-mAbs Therapeutics Insider Transactions Acelyrin Insider Transactions ProKidney Insider Transactions Humacyte Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:ADAP) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Adaptimmune Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADAP Stock Free ADAP Stock Alerts